Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19
Violetta Dymicka-Piekarska,1,* Justyna Dorf,1,* Anna Milewska,2 Mateusz Łukaszyk,3 Jakub Wiktor Kosidło,4 Joanna Kamińska,1 Blanka Wolszczak-Biedrzycka,5 Wojciech Naumnik3 1Department of Clinical Laboratory Diagnostics, Medical University of Bialystok...
I tiakina i:
Ngā kaituhi matua: | , , , , , , , |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
Dove Medical Press,
2023-05-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_3d6a3f287c4e4b50a56ebae79dbe7f73 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Dymicka-Piekarska V |e author |
700 | 1 | 0 | |a Dorf J |e author |
700 | 1 | 0 | |a Milewska A |e author |
700 | 1 | 0 | |a Łukaszyk M |e author |
700 | 1 | 0 | |a Kosidło JW |e author |
700 | 1 | 0 | |a Kamińska J |e author |
700 | 1 | 0 | |a Wolszczak-Biedrzycka B |e author |
700 | 1 | 0 | |a Naumnik W |e author |
245 | 0 | 0 | |a Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19 |
260 | |b Dove Medical Press, |c 2023-05-01T00:00:00Z. | ||
500 | |a 1178-7031 | ||
520 | |a Violetta Dymicka-Piekarska,1,* Justyna Dorf,1,* Anna Milewska,2 Mateusz Łukaszyk,3 Jakub Wiktor Kosidło,4 Joanna Kamińska,1 Blanka Wolszczak-Biedrzycka,5 Wojciech Naumnik3 1Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, Poland; 2Department of Biostatistics and Medical Informatics, Medical University of Bialystok, Białystok, Poland; 3Temporary Hospital No 2 of Clinical Hospital in Bialystok, 1st Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Białystok, Poland; 4Students Scientific Club at the Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland; 5Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland*These authors contributed equally to this workCorrespondence: Violetta Dymicka-Piekarska, Email piekarskav@yahoo.comAim: The aim of our retrospective study was search for new prognostic parameters, which can help quickly and cheaply identify patients with risk for severe course of SARS-CoV-2 infection.Materials and Methods: The following peripheral blood combination biomarkers were calculated: NLR (neutrophil/lymphocytes ratio), LMR (lymphocyte/monocyte ratio), PLR (platelet/lymphocyte ratio), dNLR (neutrophils/(white blood cells − neutrophils)), NLPR (neutrophil/(lymphocyte × platelet ratio)) in 374 patients who were admitted to the Temporary Hospital no 2 of Clinical Hospital in Bialystok (Poland) with COVID-19. The patients were divided into four groups depending on the severity of the course of COVID-19 using MEWS classification.Results: The NLR and dNLR were significantly increased with the severity of COVID-19, according to MEWS score. The AUC for the assessed parameters was higher in predicting death in patients with COVID-19: NLR (0.656, p=0.0018, cut-off=6.22), dNLR (0.615, p=0.02, cut-off=3.52) and LMR (0.609, p=0.03, cut-off=2.06). Multivariate COX regression analysis showed that NLR median above 5.56 (OR: 1.050, P=0.002), LMR median below 2.23 (OR: 1.021, P=0.011), and age > 75 years old (OR: 1.072, P=0.000) had a significant association with high risk of death during COVID-19.Conclusion: Our results indicate that NLR, dNLR, and LMR calculated on admission to the hospital can quickly and easy identify patients with risk of a more severe course of COVID-19. Increase NLR and decrease LMR have a significant predictive value in COVID-19 patient's mortality and might be a potential biomarker for predicting death in COVID-19 patients.Keywords: COVID-19, biomarker, mortality, NLR, dNLR, LMR, PLR | ||
546 | |a EN | ||
690 | |a covid-19 | ||
690 | |a biomarker | ||
690 | |a mortality | ||
690 | |a nlr | ||
690 | |a dnlr | ||
690 | |a lmr | ||
690 | |a plr | ||
690 | |a Pathology | ||
690 | |a RB1-214 | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Inflammation Research, Vol Volume 16, Pp 2209-2222 (2023) | |
787 | 0 | |n https://www.dovepress.com/neutrophillymphocyte-ratio-nlr-and-lymphocytemonocyte-ratio-lmr--risk--peer-reviewed-fulltext-article-JIR | |
787 | 0 | |n https://doaj.org/toc/1178-7031 | |
856 | 4 | 1 | |u https://doaj.org/article/3d6a3f287c4e4b50a56ebae79dbe7f73 |z Connect to this object online. |